BR112018014171A2 - composições biofotônicas para o tratamento de otite externa - Google Patents

composições biofotônicas para o tratamento de otite externa

Info

Publication number
BR112018014171A2
BR112018014171A2 BR112018014171A BR112018014171A BR112018014171A2 BR 112018014171 A2 BR112018014171 A2 BR 112018014171A2 BR 112018014171 A BR112018014171 A BR 112018014171A BR 112018014171 A BR112018014171 A BR 112018014171A BR 112018014171 A2 BR112018014171 A2 BR 112018014171A2
Authority
BR
Brazil
Prior art keywords
treatment
otitis externa
biophotonic compositions
oxidant
biophotonic
Prior art date
Application number
BR112018014171A
Other languages
English (en)
Inventor
Maria Tambella Adolfo
Spaterna Andrea
Ohayon David
Bellini Francesco
Cerquetella Matteo
Loupis Nikolaos
Piergallini Remigio
Original Assignee
Klox Tech Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klox Tech Limited filed Critical Klox Tech Limited
Publication of BR112018014171A2 publication Critical patent/BR112018014171A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Abstract

a presente divulgação descreve métodos e usos das composições biofotônicas que compreendem pelo menos um oxidante e pelo menos um cromóforo capaz de ativar o oxidante, em associação com um portador farmacologicamente aceitável para o tratamento de otite externa.
BR112018014171A 2016-01-11 2017-01-11 composições biofotônicas para o tratamento de otite externa BR112018014171A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662277263P 2016-01-11 2016-01-11
PCT/CA2017/050032 WO2017120671A1 (en) 2016-01-11 2017-01-11 Biophotonic compositions for the treatment of otitis externa

Publications (1)

Publication Number Publication Date
BR112018014171A2 true BR112018014171A2 (pt) 2018-12-11

Family

ID=59310473

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018014171A BR112018014171A2 (pt) 2016-01-11 2017-01-11 composições biofotônicas para o tratamento de otite externa

Country Status (7)

Country Link
US (2) US10610513B2 (pt)
EP (1) EP3402522A4 (pt)
JP (1) JP2019501952A (pt)
AU (1) AU2017207533B2 (pt)
BR (1) BR112018014171A2 (pt)
CA (1) CA3011156A1 (pt)
WO (1) WO2017120671A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017120671A1 (en) * 2016-01-11 2017-07-20 Klox Technologies Limited Biophotonic compositions for the treatment of otitis externa
US11857799B2 (en) 2022-01-07 2024-01-02 Soletluna Holdings, Inc. Wearable selective biophoton reflector

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141321A (en) 1963-04-12 1964-07-21 Scovill Manufacturing Co Key retaining member
US4402959A (en) 1980-06-02 1983-09-06 Merck & Co., Inc. Antimicrobial compositions
US4430381A (en) 1982-06-25 1984-02-07 The Buckeye Cellulose Corporation Monocarboxylic acid antimicrobials in fabrics
US4625026A (en) 1982-12-30 1986-11-25 Biomeasure, Inc. 2-amino-4-oxo-tricyclicpyrimidines having antiviral activities against herpes simplex virus type II infections
US4533435A (en) 1984-06-07 1985-08-06 Microban Products Company Antimicrobial paper
US4736467A (en) 1986-12-24 1988-04-12 Burlington Industries, Inc. Operating room clothing system
US4855139A (en) 1987-01-20 1989-08-08 Med. Fab (Lafayette), Inc. Fungicidally active cellulosic textile compositions, or articles of manufacture
US5453275A (en) 1988-05-05 1995-09-26 Interface, Inc. Biocidal polymeric coating for heat exchanger coils
US5091102A (en) 1988-11-15 1992-02-25 Nordico, Inc. Method of making a dry antimicrobial fabric
US5069907A (en) 1990-03-23 1991-12-03 Phoenix Medical Technology Surgical drape having incorporated therein a broad spectrum antimicrobial agent
US5567372A (en) 1993-06-11 1996-10-22 Kimberly-Clark Corporation Method for preparing a nonwoven web containing antimicrobial siloxane quaternary ammonium salts
US5894042A (en) 1996-02-26 1999-04-13 Technology Licensing Company Bacteriostatic coating of polymeric conduit
US5919554A (en) 1998-01-30 1999-07-06 Microban Products Company Antimicrobial fiberglass reinforced plastic composite
US6420455B1 (en) * 1999-06-18 2002-07-16 3M Innovative Properties Company Antimicrobial composition containing photosensitizers articles, and methods of use
US6551608B2 (en) 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
WO2006099325A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
EP1933941A2 (en) * 2005-08-25 2008-06-25 Philip R. Houle Treatment systems for delivery of sensitizer solutions
US20070255356A1 (en) * 2006-04-28 2007-11-01 Ondine International, Ltd. Photodisinfection delivery devices and methods
GB0810719D0 (en) 2008-06-11 2008-07-16 Dupont Teijin Films Us Ltd Polymeric film
CA2935819A1 (en) * 2008-11-07 2010-05-14 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
WO2012015820A1 (en) * 2010-07-30 2012-02-02 Advanced Photodynamic Technologies, Inc. Composition and method for photodynamic disinfection
KR20130011162A (ko) * 2011-07-20 2013-01-30 주식회사 호크놀러지 Ｐｄｔ를 이용한, 포유동물의 종양 또는 피부질환 치료방법
CA2862406A1 (en) * 2012-01-10 2013-07-18 Entrx LLC Otic formulations, methods and devices
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
WO2017120671A1 (en) * 2016-01-11 2017-07-20 Klox Technologies Limited Biophotonic compositions for the treatment of otitis externa

Also Published As

Publication number Publication date
US20190029994A1 (en) 2019-01-31
EP3402522A1 (en) 2018-11-21
EP3402522A4 (en) 2019-07-24
US10610513B2 (en) 2020-04-07
US20200230101A1 (en) 2020-07-23
CA3011156A1 (en) 2017-07-20
AU2017207533B2 (en) 2022-06-16
AU2017207533A1 (en) 2018-07-26
US11154532B2 (en) 2021-10-26
WO2017120671A1 (en) 2017-07-20
JP2019501952A (ja) 2019-01-24

Similar Documents

Publication Publication Date Title
DOP2019000180A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
CL2019000511A1 (es) Inhibidores de procesos metabólicos celulares.
CL2018002012A1 (es) Derivados de maitansinoide, conjugados de los mismos y métodos de uso.
CO2020015255A2 (es) Métodos y composiciones para tratar el cáncer
BR112018067368A2 (pt) terapia de combinação com anticorpos anti-cd73
CL2017003404A1 (es) Compuestos antibacterianos
CO2017001994A2 (es) Compuestos activos hacia bromodominios
CL2018000194A1 (es) Compuestos de piridina
BR112018067525A2 (pt) anticorpos tendo especificidade para o btla e seus usos
CR20150316A (es) Compuestos y sus métodos de empleo
CL2015002472A1 (es) Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4.
BR112016029226A2 (pt) métodos e composições para o tratamento de úlceras
AR096478A1 (es) Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
DOP2016000109A (es) Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas.
BR112015005301A2 (pt) composições cosméticas biofotônicas
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
BR112015029386A2 (pt) uso de eribulina e lenvatinibe como terapia de combinação para tratamento de câncer
CR20160316A (es) Compuestos derivados de hidroxiformamida y usos del mismo
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
BR112016028895A2 (pt) composições biofotônicas termofixas e usos destas
BR112016012248A2 (pt) método de tratamento de nefropatia
BR112015024703A2 (pt) formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose
BR112018014171A2 (pt) composições biofotônicas para o tratamento de otite externa
CR20160225A (es) Glicoproteínas recombinantes y sus usos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI N? 10196/2001, QUE MODIFICOU A LEI N? 9279/96, A CONCESS?O DA PATENTE EST? CONDICIONADA ? ANU?NCIA PR?VIA DA ANVISA. CONSIDERANDO A APROVA??O DOS TERMOS DO PARECER N? 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL N? 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVID?NCIAS CAB?VEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2631 DE 08/06/2021 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B25A Requested transfer of rights approved

Owner name: VETOQUINOL SA (FR)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]